Search

Displaying results 7721 - 7730 of 10000 in total
  1. Drug

    BEA-17

    go.drugbank.com/drugs/DB18574
    Experimental

    BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST.[L48330] It is under investigation for the treatment of glioblastoma.

  2. Drug

    CYNK-101

    go.drugbank.com/drugs/DB18637
    Investigational

    CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).

    Synonyms: allogeneic human placental hematopoietic stem cell derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP)
  3. Drug

    Zandatrigine

    go.drugbank.com/drugs/DB19051
    Investigational

    Zandatrigine is under investigation in clinical trial NCT05226780 (Extension Study to Evaluate How Safe and Tolerable NBI-921352 Is as an Adjunctive Therapy for Participants With SCN8A-DEE).

    Synonyms: Benzenesulfonamide, 2-fluoro-5-methyl-4-(methyl((3s)-1-(phenylmethyl)-3-pyrrolidinyl)amino)-n-4-thiazolyl-
  4. Drug

    Otamixaban

    go.drugbank.com/drugs/DB06635
    Investigational

    Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Solanezumab

    go.drugbank.com/drugs/DB11756
    Investigational

    Solanezumab is under investigation for the treatment of Dementia, Alzheimers Disease, and Alzheimers Disease, Familial.

  6. Drug

    norUrsodeoxycholic acid

    go.drugbank.com/drugs/DB16260
    Investigational

    norUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).

  7. Drug

    Poseltinib

    go.drugbank.com/drugs/DB16299
    Investigational

    Poseltinib is under investigation in clinical trial NCT02628028 (A Study of LY3337641 in Rheumatoid Arthritis).

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Sodelglitazar

    go.drugbank.com/drugs/DB16332
    Investigational

    Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).

  9. Drug

    Phorbol 12-myristate 13-acetate diester

    go.drugbank.com/drugs/DB17045
    Investigational

    Phorbol 12-myristate 13-acetate diester is an inducer of neutrophil extracellular traps (NETs).[A253087]

    Synonyms: 12-o-tetradecanoylphorbol-13-acetate
  10. Drug

    Sipagladenant

    go.drugbank.com/drugs/DB17080
    Investigational

    KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.[L43822]